The promises and perils of psychedelic pharmacology for psychiatry.
Nature reviews. Drug discovery June 1, 2022 Tristan D Mcclure-Begley, Bryan L. Roth 195 citations
Psychedelic drugs including psilocybin, N,N'-dimethyltryptamine (DMT) and lysergic acid diethylamide (LSD) are undergoing a renaissance as potentially useful drugs for various neuropsychiatric diseases, with a rapid onset of therapeutic activity. Notably, phase II trials have shown that psilocybin can produce statistically significant clinical effects following one or two administrations in...